LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Arrowhead Pharmaceuticals (NASDAQ: ARWR)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
04/09/2025
Sell
$9.93
35,305
$351K
4.03M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
04/09/2025
Sell
$10.75
3,400
$37K
4.02M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
04/09/2025
Sell
$11.76
1,617
$19K
4.02M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
04/10/2025
Sell
$10.87
50,000
$544K
3.97M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
04/11/2025
Sell
$11.49
50,800
$584K
3.92M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
03/13/2025
Sell
$15.07
51,425
$775K
4.06M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
03/04/2025
Buy
$7.75
133,333
$1.033M
4.07M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
03/03/2025
Buy
$7.75
166,667
$1.292M
3.94M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
03/03/2025
Sell
$18.03
166,667
$3.005M
3.91M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
03/04/2025
Sell
$17.02
133,333
$2.269M
3.77M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
03/03/2025
Sell
$7.75
166,667
$1.292M
185,059
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
03/03/2025
Sell
$7.75
133,333
$1.033M
51,726